Cargando…
Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq–guided combination with sapanisertib
The therapeutic potential of CDK4/6 inhibitors for brain tumors has been limited by recurrence. To address recurrence, we tested a nanoparticle formulation of CDK4/6 inhibitor palbociclib (POx-Palbo) in mice genetically-engineered to develop SHH-driven medulloblastoma, alone or in combination with s...
Autores principales: | Lim, Chaemin, Dismuke, Taylor, Malawsky, Daniel, Ramsey, Jacob D., Hwang, Duhyeong, Godfrey, Virginia L., Kabanov, Alexander V., Gershon, Timothy R., Sokolsky-Papkov, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791615/ https://www.ncbi.nlm.nih.gov/pubmed/35080986 http://dx.doi.org/10.1126/sciadv.abl5838 |
Ejemplares similares
-
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
por: Ocasio, Jennifer Karin, et al.
Publicado: (2019) -
Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy
por: Ocasio, Jennifer Karin, et al.
Publicado: (2022) -
Primary specification of blastocyst trophectoderm by scRNA-seq: New insights into embryo implantation
por: Liu, Dandan, et al.
Publicado: (2022) -
MEDB-56. POx NPs mediated delivery of (TLR7/8) agonist resiquimod improves treatment outcomes in SHH medulloblastoma by targeting tumor associated macrophages
por: Hwang, Duhyeong, et al.
Publicado: (2022) -
Human PBMC scRNA-seq–based aging clocks reveal ribosome to inflammation balance as a single-cell aging hallmark and super longevity
por: Zhu, Hongming, et al.
Publicado: (2023)